Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
02/1996
02/28/1996EP0697875A1 Use of modified tall-104 cells to treat cancer and viral diseases
02/28/1996EP0511967B1 Medicaments and methods for treating acquired immune deficiency syndrome (aids) and aids-related complex (arc) employing anti-carbohydrate antibodies
02/28/1996EP0362367B1 Osteogenic devices
02/28/1996CN1117742A Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines
02/28/1996CN1117525A Arnebia euchroma (Royle) Johnst. cell cultivation and prodn. process by solid two step method
02/27/1996US5495071 Genetic engineering
02/27/1996US5494899 Immunomodulation of bone marrow cells in culture using hormones during pregnancy, such as estrogen; autoimmune disorders, osteoporosis
02/27/1996US5494806 A genetic engineered, hybridized probe consisting of an 18-polynucleotides sequence
02/27/1996US5494792 Kainate-binding, human CNS receptors of the EAA2 family
02/27/1996US5494791 Monoclonal antibodies against glycated low density lipoprotein
02/27/1996CA2114311C Monoclonal wb b-cell line
02/27/1996CA2018228C Cell culture systems and media
02/22/1996WO1996005320A1 Adenovirus comprising a gene coding for glutathion peroxidase
02/22/1996WO1996005317A1 Ga4 dna, protein and methods of use
02/22/1996WO1996005314A2 Protein toxins active against lepidopteran pests
02/22/1996WO1996005313A1 VACCINES CONTAINING BORRELIA BURGDORFERI OspG
02/22/1996WO1996005309A2 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
02/22/1996WO1996005308A1 Method for diagnosing a predisposition for breast and ovarian cancer
02/22/1996WO1996005307A2 17q-LINKED BREAST AND OVARIAN CANCER SUSCEPTIBILITY GENE
02/22/1996WO1996005306A2 IN VIVO MUTATIONS AND POLYMORPHISMS IN THE 17q-LINKED BREAST AND OVARIAN CANCER SUSCEPTIBILITY GENE
02/22/1996WO1996005291A1 Recombinant herpesvirus of turkeys and uses thereof
02/22/1996WO1996005290A1 Bone precursor cells: compositions and methods
02/22/1996WO1996005289A1 Enhanced activation of natural killer cells using an nk cell activator and a hydrogen peroxide scavenger or inhibitor
02/22/1996WO1996005288A2 T cell activation
02/22/1996WO1996005286A2 Cell death accelerator and cell death inhibitor
02/22/1996WO1996005230A1 MONOCLONAL ANTIBODY AGAINST HUMAN Mx PROTEIN MxA
02/22/1996WO1996005225A1 Adrenergic receptor
02/22/1996WO1996005221A1 Calcitonin receptor
02/22/1996WO1996004934A1 Retroviral vectors produced by producer cell lines resistant to lysis by human serum
02/22/1996WO1996004928A1 Calcitonin gene related peptide receptor
02/22/1996WO1996004789A1 A method of selectively destroying neoplastic cells
02/22/1996WO1995025171A3 Dna sequences for matrix metalloproteases, their production and use
02/22/1996DE19503359C1 Plants with increased tolerance towards stress
02/22/1996CA2200197A1 Bone precursor cells: compositions and methods
02/22/1996CA2197801A1 T cell activation
02/22/1996CA2197753A1 Ga4 dna, protein and methods of use
02/22/1996CA2197712A1 Vaccines containing borrelia burgdorferi ospg
02/22/1996CA2196756A1 Enhanced activation of natural killer cells using an nk cell activator and a hydrogen peroxide scavenger or inhibitor
02/22/1996CA2196208A1 Retroviral vectors produced by producer cell lines resistant to lysis by human serum
02/22/1996CA2196080A1 Protein toxins active against lepidopteran pests
02/21/1996EP0516785B1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF alpha
02/20/1996US5492890 Polypeptides for promoting cell attachment
02/20/1996US5492820 Plasmids for the production of transgenic plants that are modified in habit and yield
02/20/1996US5492314 Preloaded digressive rate mount
02/15/1996WO1996004395A1 Recombinant virus vectors
02/15/1996WO1996004393A2 Control of plant gene expression
02/15/1996WO1996004391A1 Method for selecting high-expressing host cells
02/15/1996WO1996004388A1 Novel compounds
02/15/1996WO1996004387A1 Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme
02/15/1996WO1996004386A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection
02/15/1996WO1996004385A2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
02/15/1996WO1996004372A1 Ikaros transgenic cells and animals
02/15/1996WO1996004368A1 Propagation and inducible differentiation of human fetal central nervous system progenitor cells
02/15/1996WO1996004367A1 Cell culturing method
02/15/1996WO1996004314A1 Mhc complexes and uses thereof
02/15/1996WO1996004310A1 Contraceptive vaccine
02/15/1996WO1996004309A1 Monoclonal antibodies specific for an epitope of a particular subclass or form of phosphorylated tau, hybridomas secreting them, antigen recognition of these antibodies and their applications
02/15/1996WO1996003937A1 Method for modifying the internal surface of synthetic prosthesis used in vascular surgery
02/15/1996WO1996003883A1 Cells bearing cd4 decoy receptors and related molecules and methods
02/15/1996WO1996002645A3 Htk ligand
02/15/1996WO1995032285A3 Transgenic arthritic mice
02/15/1996WO1995026982A3 Malaria peptides
02/15/1996DE4427217A1 Zellkulturverfahren Cell culture method
02/15/1996CA2196285A1 Contraceptive vaccine
02/15/1996CA2196200A1 Novel compounds
02/15/1996CA2196190A1 Ikaros transgenic cells and animals
02/15/1996CA2196168A1 Recombinant virus vectors
02/15/1996CA2195672A1 Monoclonal antibodies specific for an epitope of a particular subclass or form of phosphorylated tau, hybridomas secreting them, antigen recognition of these antibodies and their applications
02/15/1996CA2195312A1 Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same
02/15/1996CA2194488A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection
02/15/1996CA2172273A1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
02/14/1996EP0696640A2 Recombinant antigen from the NS3 region of hepatitis C virus
02/14/1996EP0696639A1 Use of interferon gamma for the inhibition of proliferation and differentiation of primitive hematopoietic progenitor cells
02/14/1996EP0696597A2 Monoclonal antibodies for selective immunological determination of high molecular weight intact laminin forms in body fluids
02/14/1996EP0696320A1 Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor
02/14/1996EP0696317A1 HUMAN $i(SYK)
02/14/1996EP0696205A1 Use of neuro-derived fetal cell lines for transplantation therapy
02/14/1996EP0696163A1 Coated meristermatic tissue
02/14/1996EP0389538B1 yETHOD OF PURIFYING RECOMBINANT t-PA FROM CORRESPONDING HOST CELL PROTEINS
02/14/1996CN1116655A Process for gene tranfer into plant cells
02/14/1996CN1116654A Preserved, non-infectious control cells for use in the identification of a disease through blood testing
02/14/1996CN1116549A High affinity tumor killer cell (T-AK cell) preparation
02/14/1996CA2155920A1 Use of interferon for the inhibition of proliferation and differentiation of primitive hematopoietic progenitor cells
02/13/1996US5491288 Chimeric gene comprising the arabidopsis histone H4 promoter for the transformation of plants
02/13/1996US5491284 Nude mouse model for neoplastic disease
02/13/1996US5491090 Embryogenic coniferous liquid suspension cultures
02/13/1996US5491088 Genetic engineering
02/13/1996US5491080 Genetic engineering of integrating a dna sequence encoding a protein specifically breaking a double-strain rna into a plant chromosome
02/13/1996US5491073 Cloning of chicken anaemia DNA
02/13/1996US5491066 Specifically reacts with active human ceruloplasmin; diagnosis of wilson's disease
02/13/1996US5491065 Monoclonal antibodies that bind to and neutralize dimeric but not monomeric human M-CSF and methods of use thereof for detection of dimeric M-CSF
02/08/1996WO1996003649A1 Src SH3 BINDING PEPTIDES AND METHODS OF ISOLATING AND USING SAME
02/08/1996WO1996003522A1 Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same
02/08/1996WO1996003520A1 Methods for the preparation of retroviral particles and cell lines deficient in the alpha-galactosyl epitope
02/08/1996WO1996003519A1 Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same
02/08/1996WO1996003515A2 Surface expression of enzyme in gene directed prodrug therapy
02/08/1996WO1996003513A2 Isoamylase gene from flaviobacterium sp., compositions containing it and methods using it
02/08/1996WO1996003504A1 Cloning and expression of an acetylcholine-gated ion channel receptor subunit
02/08/1996WO1996003496A1 Culture medium promoting endocrine cell growth
02/08/1996WO1996003495A1 Bradykinin b2 receptor modified transgenic non-human animals